Pasithea Therapeutics Corp. (KTTA) vs Pulsenmore Ltd. Ordinary Shares (PLSM)
A side-by-side comparison of Pasithea Therapeutics Corp. and Pulsenmore Ltd. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KTTA
Pasithea Therapeutics Corp.
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PLSM
Pulsenmore Ltd. Ordinary Shares
$2.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KTTA vs PLSM
growth of $100 · dividends reinvested · last 1yKTTA -50.9% (-50.9%/yr)PLSM -70.0% (-70.0%/yr)KTTA compounded faster over this window
KTTA PLSM
KTTA vs PLSM: by the numbers
- •KTTA is the larger company ($15M vs $14M market cap).
- •Both run net losses; KTTA's is the smaller (0.00% vs -39.61% net margin).
Metrics side by side
Valuation
| Metric | KTTA | PLSM |
|---|---|---|
| P/B ratio | 0.30 | 0.86 |
Profitability
| Metric | KTTA | PLSM |
|---|---|---|
| Gross margin | 0.00% | 84.15% |
| Operating margin | 0.00% | -30.39% |
| Net margin | 0.00% | -39.61% |
| ROE | -42.72% | -19.08% |
| ROIC | -48.04% | -13.15% |
Growth (annualized)
| Metric | KTTA | PLSM |
|---|---|---|
| Total return CAGR (5Y) | -61.48% | N/A |
Go deeper
Dig into the metrics
Pasithea Therapeutics ROEPulsenmore Ltd. Ordinary Shares ROEPasithea Therapeutics operating marginPulsenmore Ltd. Ordinary Shares operating marginPasithea Therapeutics revenue growthPulsenmore Ltd. Ordinary Shares revenue growthPasithea Therapeutics free cash flowPulsenmore Ltd. Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.